Skip to results
Modify your search
NARROW
1-20 of 32
Authors: Peng Zhang
Journal Article
ACCEPTED MANUSCRIPT
Dual αVβ8 Integrin and PD-1 Blockade Overcomes TGFβ-Mediated B-Cell Suppression to Enhance Anti-Glioma Immunity
Neuro-Oncology, noaf106, https://doi.org/10.1093/neuonc/noaf106
Published: 22 April 2025
Journal Article
IMMU-25. B-CELL BASED THERAPY (BVAX) PRODUCES ANTIBODIES TO SUPPRESS GLIOBLASTOMA TUMOR MIGRATION AND INVASION
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii157–viii158, https://doi.org/10.1093/neuonc/noae165.0618
Published: 11 November 2024
Journal Article
IMMU-54. THERAPEUTIC TARGETING OF STING IN MENINGIOMAS
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii164, https://doi.org/10.1093/neuonc/noae165.0646
Published: 11 November 2024
Journal Article
DDEL-03. INTRANASAL DELIVERY OF PDGFRA-TARGETED NANOTHERAPEUTICS FOR THE TREATMENT OF PEDIATRIC HIGH-GRADE GLIOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii121, https://doi.org/10.1093/neuonc/noae165.0470
Published: 11 November 2024
Journal Article
EDITOR'S CHOICE
Is modulation of immune checkpoints on glioblastoma-infiltrating myeloid cells a viable therapeutic strategy?
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 33–49, https://doi.org/10.1093/neuonc/noae193
Published: 19 October 2024
Journal Article
Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood–brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas Get access
Neuro-Oncology, Volume 26, Issue 11, November 2024, Pages 2044–2060, https://doi.org/10.1093/neuonc/noae135
Published: 19 July 2024
Journal Article
HGG-51. INTRANASAL DELIVERY OF PDGFRA-IMMUNOLIPOSOMAL SN-38 FOR THE TREATMENT OF PEDIATRIC HIGH-GRADE GLIOMAS
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.335
Published: 18 June 2024
Journal Article
IMMU-31. B-CELL THERAPY (BVAX) PROMOTES CD8 T CELLS' PERSISTENCE AND FUNCTION IN THE GLIOBLASTOMA MICROENVIRONMENT BY MAINTAINING THEIR STEM-LIKE FEATURES
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v148–v149, https://doi.org/10.1093/neuonc/noad179.0563
Published: 10 November 2023
Journal Article
IMMU-07. THE CXCL16/CXCR6 AXIS REGULATES CD8+ T-CELL RECRUITMENT AND FUNCTION IN GLIOBLASTOMA
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v142, https://doi.org/10.1093/neuonc/noad179.0539
Published: 10 November 2023
Journal Article
EXTH-24. FC-ENHANCED ANTI-CTLA-4 IMMUNE CHECKPOINT BLOCKADE AND ITS COMBINATION WITH ANTI-PD-1 WITH CONCOMITANT DOXORUBICIN AND ULTRASOUND-MEDIATED BBB OPENING: A NOVEL IMMUNOTHERAPY FOR GLIOBLASTOMA
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v228–v229, https://doi.org/10.1093/neuonc/noad179.0877
Published: 10 November 2023
Journal Article
EXTH-52. HARNESSING A B CELL THERAPY TO PROMOTE ANTI-GLIOBLASTOMA HUMORAL RESPONSE
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii220–vii221, https://doi.org/10.1093/neuonc/noac209.850
Published: 14 November 2022
Journal Article
TMIC-42. LEVERAGING B CELL IMMUNITY TO PROMOTE IMMUNOTHERAPY IN GLIOBLASTOMA
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii280, https://doi.org/10.1093/neuonc/noac209.1086
Published: 14 November 2022
Journal Article
EXTH-29. DUAL TGFB AND PD1 BLOCKADE PROMOTES GERMINAL-CENTER B-CELL IMMUNE RESPONSES AGAINST GLIOBLASTOMA
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi169, https://doi.org/10.1093/neuonc/noab196.668
Published: 12 November 2021
Journal Article
IMMU-29. B-CELL-BASED VACCINE PRODUCES GLIOBLASTOMA-REACTIVE ANTIBODIES THAT CONTRIBUTE TO TUMOR CLEARANCE
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi98, https://doi.org/10.1093/neuonc/noab196.388
Published: 12 November 2021
Journal Article
TAMI-25. UPREGULATION OF CREATINE METABOLISM BY MYELOID CELLS RESULTS IN GLIOBLASTOMA PROGRESSION
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi203, https://doi.org/10.1093/neuonc/noab196.809
Published: 12 November 2021
Journal Article
IMMU-36. B CELL-VACCINE ELICITS LONG TERM IMMUNITY AGAINST GLIOBLASTOMA VIA ACTIVATION AND DIFFERENTIATION OF TUMOR-SPECIFIC CD8+ MEMORY T CELLS
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi100, https://doi.org/10.1093/neuonc/noab196.395
Published: 12 November 2021
Journal Article
EMBR-02. OLIG2 REPRESENTS A PROGNOSTIC MARKER AND THERAPEUTIC TARGET IN MYC-AMPLIFIED MEDULLOBLASTOMA RELAPSE AND METASTASIS
Neuro-Oncology, Volume 23, Issue Supplement_1, June 2021, Pages i5–i6, https://doi.org/10.1093/neuonc/noab090.020
Published: 01 June 2021
Journal Article
BIOM-55. DGKζ-TARGETED REGULATION OF MIR-34A IN THE PROLIFERATION AND TUMORIGENICITY OF HUMAN GLIOBLASTOMA
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii13, https://doi.org/10.1093/neuonc/noaa215.052
Published: 09 November 2020
Journal Article
EXTH-43. GENERATION OF A B-CELL-BASED VACCINE FOR THE TREATMENT OF GLIOBLASTOMA
Neuro-Oncology, Volume 22, Issue Supplement_2, November 2020, Page ii96, https://doi.org/10.1093/neuonc/noaa215.397
Published: 09 November 2020
Journal Article
RDNA-05. RADIOTHERAPY PROMOTES ONCOPROGRESSIVE CROSSTALK BETWEEN GLIOBLASTOMA TUMOR CELLS AND M2 MACROPHAGES VIA THE NLRP3 INFLAMMASOME PATHWAY
Neuro-Oncology, Volume 21, Issue Supplement_6, November 2019, Pages vi207–vi208, https://doi.org/10.1093/neuonc/noz175.865
Published: 11 November 2019
